Prime Medicine (PRME) Other financing activities (2022 - 2026)

Prime Medicine's (PRME) quarterly Other financing activities came in at $393000.0 in Q1 2026, down 49.68% on a QoQ basis from $781000.0 in Q4 2025.

Prime Medicine (PRME) Other financing activities (2022 - 2026) Analysis & Trends

Prime Medicine (PRME) has 5 years of Other financing activities data on file, last reported at $393000.0 in Q1 2026.

  • Quarterly Other financing activities changed N/A year-over-year to $393000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.2 million (down 93.33% YoY) and the FY2025 annual result came in at $781000.0, down 95.85% from the prior year.
  • Other financing activities eased to $393000.0 in Q1 2026, from $781000.0 in the prior quarter.
  • In the past five years, Other financing activities ranged from a high of $17.6 million in Q2 2024 to a low of -$68000.0 in Q2 2023.
  • A 5-year average of $2.1 million and a median of $293500.0 in 2023 frame the typical range for Other financing activities.
  • Annual changes were most pronounced in 2023 — Other financing activities gained 24.36% — and 2024, when it jumped 25982.35%.
  • Tracing PRME's Other financing activities over 5 years: stood at $156000.0 in 2022, then advanced by 24.36% to $194000.0 in 2023, then jumped by 8972.16% to $17.6 million in 2024, then slumped by 95.56% to $781000.0 in 2025, then slumped by 49.68% to $393000.0 in 2026.
  • The last three Other financing activities figures came in at $393000.0 (Q1 2026), $781000.0 (Q4 2025), and $17.6 million (Q2 2024), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn
4 Revolution Medicines 43.64 Bn 43.64 Bn -
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn
7 Royalty Pharma 33.72 Bn 35.84 Bn -
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn
10 Prime Medicine 558.48 Mn 558.48 Mn -

Historic Data

Download Data
DateValue
Jun 30, 2026 23,000.00
Jun 30, 2026 23,000.00
Mar 31, 2026 393,000.00
Mar 31, 2026 393,000.00
Dec 31, 2025 781,000.00
Dec 31, 2025 781,000.00
Jun 30, 2024 17.60 Mn
Jun 30, 2024 17.60 Mn
Mar 31, 2024 1.20 Mn
Mar 31, 2024 1.20 Mn
Dec 31, 2023 194,000.00
Dec 31, 2023 194,000.00
Sep 30, 2023 461,000.00
Sep 30, 2023 461,000.00
Jun 30, 2023 -68,000.00
Jun 30, 2023 -68,000.00
Mar 31, 2023 68,000.00
Mar 31, 2023 68,000.00
Dec 31, 2022 156,000.00
Dec 31, 2022 156,000.00